NCT06369155: Azenosertib in Uterine Serous Carcinoma: Biomarker Study
- State
- Under way
- Phase
- Phase 2
- People
- 25 planned
- Started
- 5 Mar 2025
- Primary completion
- 31 Jan 2027
- Arms
- Azenosertib
- Results
- None posted
- 16 Apr 2024: Trial registered
- 5 Mar 2025: Trial started